Agios Pharmaceuticals Inc (AGIO) Q1 2025 Earnings Call Recap: Navigating Challenges and Driving Strategic Growth
2025-05-02
YAHOO!Finance
Agios Pharmaceuticals Inc (AGIO) has reported a 6% revenue increase in its Q1 2025 earnings call, highlighting the company's resilience amidst revenue and expense challenges. The pharmaceutical company has also outlined promising pipeline development ...Read more
